Skip to Content
Merck
  • Extragastrointestinal stromal tumors: Computed tomography and magnetic resonance imaging findings.

Extragastrointestinal stromal tumors: Computed tomography and magnetic resonance imaging findings.

Oncology letters (2014-12-02)
Jingqi Zhu, Zhangwei Yang, Guangyu Tang, Zhongqiu Wang
ABSTRACT

Extragastrointestinal stromal tumors (EGISTs) are rare mesenchymal tumors that originate outside the gastrointestinal tract. The aim of the present study was to investigate the computed tomography (CT) and magnetic resonance imaging (MRI) features of EGISTs and analyze the correlations between radiological findings and pathological features. CT and MRI images of 24 patients with EGISTs were reviewed retrospectively. Patient demographics and tumor characteristics, including localization, size, contours, borders, cystic-necrotic components, calcification, hemorrhage, tumor vessels, attenuation and intensity, degree and pattern of enhancement, ascites, tumor invasion, lymphadenopathy and distant metastasis were recorded. Statistical analyses to compare the radiological characteristics of low- and high-grade EGISTs were performed with χ

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Meglumine, 99.0-100.5% dry basis, meets USP testing specifications
Supelco
Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material
Meglumine, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
N-Methyl-D-glucamine, ReagentPlus®, ≥99.0% (T)
Sigma-Aldrich
N-Methyl-D-glucamine, 99.0-100.5% (titration)